Immunological Effects of the PE/PPE Family Proteins of and Related Vaccines
Overview
Authors
Affiliations
Tuberculosis (TB) is a chronic infectious disease caused by (), and its incidence and mortality are increasing. The BCG vaccine was developed in the early 20th century. As the most widely administered vaccine in the world, approximately 100 million newborns are vaccinated with BCG every year, which has saved tens of millions of lives. However, due to differences in region and race, the average protective rate of BCG in preventing tuberculosis in children is still not high in some areas. Moreover, because the immune memory induced by BCG will weaken with the increase of age, it is slightly inferior in preventing adult tuberculosis, and BCG revaccination cannot reduce the incidence of tuberculosis again. Research on the mechanism of and the development of new vaccines against TB are the main strategies for preventing and treating TB. In recent years, Pro-Glu motif-containing (PE) and Pro-Pro-Glu motif-containing (PPE) family proteins have been found to have an increasingly important role in the pathogenesis and chronic protracted infection observed in TB. The development and clinical trials of vaccines based on antigens are in progress. Herein, we review the immunological effects of PE/PPE proteins and the development of common PE/PPE vaccines.
Ehtram A, Shariq M, Quadir N, Jamal S, Pichipalli M, Zarin S Front Immunol. 2025; 16:1517822.
PMID: 39949767 PMC: 11821933. DOI: 10.3389/fimmu.2025.1517822.
Liu W, Wang J, Lei Y, Liu P, Han Z, Wang S Infect Drug Resist. 2025; 18():31-42.
PMID: 39776757 PMC: 11706012. DOI: 10.2147/IDR.S482584.
In silico design of multi-epitope adhesin protein vaccines.
Pillay K, Chiliza T, Senzani S, Pillay B, Pillay M Heliyon. 2024; 10(18):e37536.
PMID: 39323805 PMC: 11422057. DOI: 10.1016/j.heliyon.2024.e37536.
Point-of-care testing of in using multiply-primed-RCA coupled with CRISPR/Cas12a.
Sun Y, Wu Y, Wang Y, Li K, Chang Y, Wei L Heliyon. 2024; 10(18):e37640.
PMID: 39309806 PMC: 11416492. DOI: 10.1016/j.heliyon.2024.e37640.
Wei J, Guo F, Song Y, Feng T, Wang Y, Xu K Cell Mol Biol Lett. 2024; 29(1):70.
PMID: 38741147 PMC: 11089708. DOI: 10.1186/s11658-024-00585-7.